Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2020-02-11

Clinical Trial Update: Measurement of Patient Reported Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Renal Transplant Recipients (MyLife) [Phase 4]

View source ↗

Summary

Phase 4 trial update focusing on patient-reported GI and health-related quality of life outcomes in renal transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Novartis | Conditions: Renal Transplantation, Gastrointestinal Problems | Phase 4 | Status: COMPLETED